Investigator Initiated Trial to Study Duobrii® Lotion in the Treatment of Mild Plaque Psoriasis in Adults

Status:
Not yet recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

This study seeks to evaluate the safety, tolerability, and efficacy of topical Duobrii® Lotion in adult subjects with mild plaque psoriasis.

Phase 3

Austin Institute for Clinical Research

OrthoDermatologics